{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:02:30Z","timestamp":1745812950759,"version":"3.40.4"},"reference-count":14,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>T-cell prolymphocytic leukaemia (T-PLL) is an extremely uncommon haematological malignancy that has an aggressive course and a grave prognosis. We describe a patient who presented with lymphocytosis, scalp erythema, ascites and splenomegaly and was diagnosed with T-PLL. He was treated with alemtuzumab with a good response and was referred for allogeneic stem cell transplantation.<\/jats:p>","DOI":"10.1136\/bcr-2013-009808","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T07:52:45Z","timestamp":1367567565000},"page":"bcr2013009808","source":"Crossref","is-referenced-by-count":1,"title":["T-cell prolymphocytic leukaemia (T-PLL): a rare disease with a grave prognosis"],"prefix":"10.1136","volume":"2013","author":[{"given":"Abhirami","family":"Vivekanandarajah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Paul","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,5,2]]},"reference":[{"key":"2025042707484741000_2013.may02_1.bcr2013009808.1","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/sj.leu.2404877","article-title":"Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv (14)(q11q32)","volume":"2013","author":"Durig","year":"2007","journal-title":"Leukemia"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-4608(97)00410-X","article-title":"Abnormalities of chromosomes 8, 11, 14 and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization","volume":"2013","author":"Maljaei","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2162-3619-1-21","article-title":"\u2018T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach","volume":"2013","author":"Tirado","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2012-01-380139","article-title":"How I treat prolymphocytic leukemia?","volume":"2013","author":"Dearden","year":"2012","journal-title":"Blood"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.5","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"2013","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.6","first-page":"164","article-title":"T-small lymphocyte disorders","volume":"2013","author":"Bartlett","year":"1999","journal-title":"Semin Hematol"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood.V40.6.777.777","article-title":"Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases","volume":"2013","author":"Preud'homme","year":"1972","journal-title":"Blood"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.8","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood.V87.8.3520.bloodjournal8783520","article-title":"Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia","volume":"2013","author":"Matutes","year":"1996","journal-title":"Blood"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.9","first-page":"867","article-title":"Is there a T-cell form of chronic lymphocytic leukemia?","volume":"2013","author":"Foon","year":"1992","journal-title":"Leukemia"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.10","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V98.6.1721","article-title":"High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H","volume":"2013","author":"Dearden","year":"2001","journal-title":"Blood"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.11","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1200\/JCO.1997.15.7.2667","article-title":"Treatment of T-cell prolymphocytic leukemia with human CD52 antibody","volume":"2013","author":"Pawson","year":"1997","journal-title":"J Clin Oncol"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.2002.20.1.205","article-title":"Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed","volume":"2013","author":"Keating","year":"2002","journal-title":"J Clin Oncol"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1701127","article-title":"Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation","volume":"2013","author":"Collins","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2025042707484741000_2013.may02_1.bcr2013009808.14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2257.2005.00690.x","article-title":"Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility","volume":"2013","author":"Curtin","year":"2005","journal-title":"Clin Lab Haematol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-009808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:48:53Z","timestamp":1745765333000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-009808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,2]]},"references-count":14,"alternative-id":["10.1136\/bcr-2013-009808"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-009808","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,5,2]]}}}